Intellectual Property

Intellectual Property

Management Approach:

The Company is committed to strengthening intellectual property management by integrating operational goals, R&D, and business resources to establish comprehensive strategies for the development and management of intellectual property rights. These efforts aim to enhance innovation capabilities, increase competitiveness, and protect core technologies and research achievements. At the same time, the Company promotes an intellectual property management system in accordance with international standards, continuously optimizing the planning and maintenance of patents and trademarks to safeguard corporate assets and foster sustainable development.

Intellectual Property Management System

A. Patent and trademark management

  1. The Company irregularly engages external patent firms to carry out patent and trademark maintenance, inventory and application portfolio planning. The patents and trademarks in possession of the Company will be mainly used for pharmaceutical products manufactured or sold by the Company and its affiliates.
  2. The employment contract and related attachments signed between the Company and the employees stipulates that during the period of employment, the inventions, discoveries, improvement methods, operating procedures and other knowledge developed, researched and conceived by employees, either alone or jointly with others, shall be held by the Company in terms of the right of use, income and ownership, except for those rights and interests which belongs to employees under applicable laws.

B. Trade secret management

The employment contract and related attachments signed between the Company and the employees stipulates that:

  1. During the employee’s employment with the Company and after the termination of the employment, employees shall be under obligations of confidentiality with respect to confidential information known or possessed by them about the Company, and shall not disclose, inform, deliver it to any third party or make it publicly available.
  2. Employees will promptly notify the Company upon being aware of any misuse or unlawful theft, disclosure or exploitation of the Company’s confidential information so that the Company can take the necessary protective measures to protect its confidential information.
  3. Employees will not disclose any of their former employers’ confidential information during the employee’s employment with the Company.

C. Copyright Management

The Company intends to conduct periodic inventories of related works completed by the Company in connection with its manufacturing, research and development operations in order to safeguard the rights and interests of the Company’s works.

Implementation of the Intellectual Property Management

A. Intellectual Property Inventory

  1. As of October 29, 2024, the Company has completed the inventory and maintenance of 38 patents and 218 trademarks.
  2. These patents and trademarks primarily cover pharmaceutical and healthcare products, with assistance from professional firms for inventory, maintenance, and application portfolio planning.

B. Education and Training on Intellectual Property Management

  1. This year, the Company conducted training on protection of trade secret, with a total of 184 participants and 92 training hours.
  2. The training content included fundamental knowledge of intellectual property rights, enhancing employees’ understanding of the importance of trade secret.

C. Future Development Directions

  1. Aligning with its operational needs, the Company will develop a global intellectual property management plan to ensure systematic management and protection of assets.
  2. The Company will continue to promote intellectual property-related education and training and plans to obtain Taiwan Intellectual Property Management System (TIPS) certification to further enhance management capabilities and international competitiveness.

Making Success More Certain

Our team is here to discuss how we can become a trusted partner to help bring your breakthrough drug successfully to market.